| |
| |
|
| Insider
Information: |
Sabella Lauren M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
257,061 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,101,638 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
257,061 |
|
|
| Total
Value |
$1,101,638 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief Operating Officer |
2022-09-03 |
10,710 |
|
0 |
Premium* |
|
|
MannKind Corp |
MNKD |
|
2024-03-27 |
246,351 |
2023-05-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial DvlpmntOff |
• – – |
2010-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| MNKD |
MannKind Corp |
EVP Chief Operating Officer |
• – – |
2023-12-31 |
4 |
A |
$3.09 |
$2,197 |
D/D |
711 |
248,145 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-11-05 |
4 |
D |
$20.28 |
$15,149 |
D/D |
(747) |
6,759 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2019-02-22 |
4 |
S |
$13.18 |
$10,028 |
D/D |
(761) |
5,092 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2021-09-03 |
4 |
D |
$4.38 |
$6,618 |
D/D |
(1,511) |
12,221 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Operating Officer |
• – – |
2022-09-03 |
4 |
D |
$0.40 |
$601 |
D/D |
(1,511) |
10,710 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2019-12-02 |
4 |
AS |
$1.60 |
$2,421 |
D/D |
(1,513) |
12,624 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2017-12-01 |
4 |
AS |
$20.53 |
$34,289 |
D/D |
(1,670) |
14,679 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-03-08 |
4 |
D |
$25.65 |
$53,480 |
D/D |
(2,085) |
18,453 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,200 |
7,506 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
2,200 |
5,853 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2016-12-01 |
4 |
AS |
$20.74 |
$50,381 |
D/D |
(2,429) |
11,949 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2020-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,015 |
15,639 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2014-12-01 |
4 |
AS |
$35.58 |
$115,344 |
D/D |
(3,242) |
15,161 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-06-28 |
4/A |
AS |
$27.84 |
$105,068 |
D/D |
(3,774) |
7,391 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2010-12-01 |
4 |
AS |
$26.53 |
$104,342 |
D/D |
(3,933) |
21,067 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2011-12-01 |
4 |
AS |
$22.91 |
$99,979 |
D/D |
(4,364) |
27,016 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2012-12-04 |
4 |
AS |
$24.58 |
$107,259 |
D/D |
(4,364) |
31,652 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-12-03 |
4 |
AS |
$20.20 |
$106,737 |
D/D |
(5,191) |
1,568 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,859 |
20,538 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2018-06-28 |
4 |
AS |
$27.84 |
$163,140 |
D/D |
(5,859) |
5,306 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2014-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
18,403 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Commercial Officer |
• – – |
2015-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,323 |
21,484 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2013-12-02 |
4 |
AS |
$33.52 |
$221,319 |
D/D |
(6,603) |
21,200 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Exec. VP-Commercial Dvlpmnt |
• – – |
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,100 |
38,752 |
0 |
- |
|
41 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
